Latest Quarterly Activity Reports News

Ten Sixty Four Limited’s latest quarterly report reveals a notable decline in gold production alongside increased all-in sustaining costs, as the company advances its mine development and navigates a complex restructuring process.

Health and Plant Protein Group Limited reported a decline in cash reserves to $0.90 million for Q2 FY25, continuing its efforts to resolve a US tax withholding issue tied to a previous asset sale.

Pure Foods Tasmania reports improved revenue and gross profit margin for 2Q25, driven by aggressive cost-cutting and operational efficiencies, while continuing negotiations to lift its ASX trading suspension.

Adelong Gold Limited's December 2024 quarterly report reveals promising new drill targets near the Adelong Mill and a binding farm-in agreement with Great Divide Mining to accelerate gold production.

Jindalee Lithium’s latest quarterly report confirms a 63-year life for its McDermitt Lithium Project, underpinned by robust financial metrics and a maiden ore reserve that taps just a fraction of its vast resource.

Red Sky Energy's December 2024 report reveals steady production from Yarrow 3, imminent fracture stimulation at Yarrow 1, and a transformative 35% stake in Angola's Block 6/24, positioning the company for diversified growth and enhanced cash flow.

Jade Gas Holdings has made significant strides in its coal bed methane project in Mongolia, completing key wells and securing A$3.63 million to accelerate its gas production strategy targeting 2025 gas flows.

Arrow Minerals reports a breakthrough at its Niagara Bauxite Project with high-grade mineralisation over 14km² and advances metallurgical testwork at Simandou North, backed by a $7 million funding round.

Cauldron Energy’s December quarter report highlights a breakthrough uranium discovery at Manyingee South within the Yanrey Project, alongside a successful $4 million capital raise to fund ongoing exploration.

Lincoln Minerals reports compelling Pre-Feasibility Study results for its Kookaburra Graphite Project, alongside strategic cost reductions and exploration progress in uranium and base metals on South Australia's Eyre Peninsula.

Opthea Limited reports steady progress in its Phase 3 trials for sozinibercept, a novel treatment for wet AMD, supported by a strong cash position and a recent R&D tax incentive.

Winchester Energy Limited reported steady production levels alongside ongoing cost reduction efforts in its December 2024 quarterly report, highlighting operational resilience despite currency headwinds.